JPS4916435B1 - - Google Patents

Info

Publication number
JPS4916435B1
JPS4916435B1 JP3545969A JP3545969A JPS4916435B1 JP S4916435 B1 JPS4916435 B1 JP S4916435B1 JP 3545969 A JP3545969 A JP 3545969A JP 3545969 A JP3545969 A JP 3545969A JP S4916435 B1 JPS4916435 B1 JP S4916435B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3545969A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4916435B1 publication Critical patent/JPS4916435B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12Triazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP3545969A 1968-05-08 1969-05-08 Pending JPS4916435B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS339968 1968-05-08

Publications (1)

Publication Number Publication Date
JPS4916435B1 true JPS4916435B1 (enExample) 1974-04-22

Family

ID=5373920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3545969A Pending JPS4916435B1 (enExample) 1968-05-08 1969-05-08

Country Status (12)

Country Link
JP (1) JPS4916435B1 (enExample)
AT (1) AT306930B (enExample)
BE (1) BE732268A (enExample)
BR (1) BR6908600D0 (enExample)
CA (1) CA921904A (enExample)
CH (1) CH527207A (enExample)
DE (1) DE1922702A1 (enExample)
ES (1) ES366910A1 (enExample)
FR (1) FR2008048A1 (enExample)
GB (1) GB1227691A (enExample)
IT (1) IT1037009B (enExample)
NL (1) NL6906909A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022535386A (ja) * 2019-06-07 2022-08-08 ルートヴィヒ-マクシミリアン-ウニヴェルズィテート ミュンヘン 炭素環ヌクレオシド類似体

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2012888C3 (de) * 1970-03-14 1981-04-02 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden
US6905669B2 (en) 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US6887855B2 (en) 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US7038038B2 (en) 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US20060014949A1 (en) * 2004-07-13 2006-01-19 Supergen Inc. Compositions and formulations of decitabine polymorphs and methods of use thereof
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
EP2073803B1 (en) 2006-10-12 2018-09-19 Astex Therapeutics Limited Pharmaceutical combinations
DK3692983T3 (da) 2008-05-15 2021-09-20 Celgene Corp Orale formuleringer af cytidinanaloger og fremgangsmåder til anvendelse deraf
WO2010017547A1 (en) 2008-08-08 2010-02-11 Scinopharm Taiwan Ldt. Process for making 5-azacytosine nucleosides and their derivatives
BR112013025167A2 (pt) 2011-03-31 2019-09-24 Celgene Int Sarl processo para preparar 5-azacitidina, ou um sal, solvato, hidrato, ou seu polimorfo, sal de 5-azacitidina, 5-azacitidina, ou um sal, solvato, hidrato, ou polimorfo
CN108635367B (zh) 2011-08-30 2020-08-21 阿斯泰克斯制药公司 地西他滨衍生物制剂
CA2991167A1 (en) 2015-07-02 2017-01-05 Otsuka Pharmaceutical Co., Ltd. Lyophilized pharmaceutical compositions
WO2017090264A1 (ja) 2015-11-27 2017-06-01 大原薬品工業株式会社 5-アザシチジン又は其の2'-デオキシ体の5'位ジベンジル燐酸エステル
JP6162349B1 (ja) 2016-04-21 2017-07-12 大原薬品工業株式会社 5−アザシチジン類の糖部シリルエーテル誘導体
US10227374B2 (en) 2016-04-21 2019-03-12 Ohara Pharmaceutical Co., Ltd. Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety
WO2017183215A1 (ja) 2016-04-21 2017-10-26 大原薬品工業株式会社 5-アザシチジン類の糖部シリルエーテル誘導体
JP2020529409A (ja) 2017-08-03 2020-10-08 大塚製薬株式会社 薬物化合物およびその精製方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022535386A (ja) * 2019-06-07 2022-08-08 ルートヴィヒ-マクシミリアン-ウニヴェルズィテート ミュンヘン 炭素環ヌクレオシド類似体

Also Published As

Publication number Publication date
AT306930B (de) 1973-04-25
BE732268A (enExample) 1969-10-01
NL6906909A (enExample) 1969-11-11
IT1037009B (it) 1979-11-10
GB1227691A (enExample) 1971-04-07
CA921904A (en) 1973-02-27
CH527207A (de) 1972-08-31
DE1922702A1 (de) 1969-11-20
BR6908600D0 (pt) 1973-02-22
FR2008048A1 (enExample) 1970-01-16
ES366910A1 (es) 1971-03-16

Similar Documents

Publication Publication Date Title
AU1946070A (enExample)
AU428130B2 (enExample)
JPS4916435B1 (enExample)
AU2374870A (enExample)
AU416157B2 (enExample)
AU429879B2 (enExample)
AU2581067A (enExample)
AU4811568A (enExample)
AU421558B1 (enExample)
AU2580267A (enExample)
AU3789668A (enExample)
AU3224368A (enExample)
AR203075Q (enExample)
BE727768A (enExample)
BE727040A (enExample)
BE726479A (enExample)
BE726277A (enExample)
BE726242A (enExample)
BE725196A (enExample)
BE724436A (enExample)
BE723943A (enExample)
BE723559A (enExample)
BE722159A (enExample)
BE719619A (enExample)
AU2496167A (enExample)